Changes in Gab2 Phosphorylation and Interaction Partners in Response to Interleukin (IL)-2 Stimulation in T-lymphocytes

Overview

Journal Sci Rep

Specialty Science

Date 2016 Mar 31

PMID 27025927

Citations 5

Authors

Nerea Osinalde

Virginia Sanchez-Quiles

Blagoy Blagoev

Irina Kratchmarova

Affiliations

Soon will be listed here.

Abstract

Interleukin-2 (IL-2) stimulation results in T-cell growth as a consequence of activation of highly sophisticated and fine-tuned signaling pathways. Despite lacking intrinsic enzymatic activity, scaffold proteins such as Gab2, play a pivotal role in IL-2-triggered signal transduction integrating, diversifying and amplifying the signal by serving as a platform for the assembly of effectors proteins. Traditionally, Gab2-mediated protein recruitment was believed to solely depend on cytokine-induced phosphotyrosine moieties. At present, phosphorylation on serine/threonine residues is also emerging as a key mediator of Gab2-dependent signal regulation. Despite its relevance, IL-2-triggered regulation on Gab2 phosphorylation is yet poorly understood. Combining antibody- and TiO2-based enrichment of the scaffold protein with SILAC quantitative mass spectrometry we disclose the prominent regulation IL-2 exerts on Gab2 serine/threonine phosphorylation by showing that at least 18 serines and 1 threonine, including previously non-reported ones, become phosphorylated in response to cytokine stimulation. Additionally, we decipher the interactome of the docking protein in resting and cytokine-treated T-lymphocytes and besides well-known Gab2 interactors we discover three novel cytokine-inducible Gab2-binding proteins. Thus, our data provide novel insights and a wealth of candidates for future studies that will shed light into the role of Gab2 in IL-2-initiated signal transduction.

Citing Articles

Setting sail: Maneuvering SHP2 activity and its effects in cancer.

Welsh C, Allen S, Madan L Adv Cancer Res. 2023; 160:17-60.

PMID: 37704288 PMC: 10500121. DOI: 10.1016/bs.acr.2023.03.003.

Gab2 and Gab3 Redundantly Suppress Colitis by Modulating Macrophage and CD8 T-Cell Activation.

Wang Z, Vaughan T, Zhu W, Chen Y, Fu G, Medrzycki M Front Immunol. 2019; 10:486.

PMID: 30936879 PMC: 6431666. DOI: 10.3389/fimmu.2019.00486.

Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer.

Li X, Mak V, Zhou Y, Wang C, Wong E, Sharma R Nat Commun. 2019; 10(1):716.

PMID: 30755611 PMC: 6372715. DOI: 10.1038/s41467-019-08574-7.

Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression.

Schmiedel B, Singh D, Madrigal A, Valdovino-Gonzalez A, White B, Zapardiel-Gonzalo J Cell. 2018; 175(6):1701-1715.e16.

PMID: 30449622 PMC: 6289654. DOI: 10.1016/j.cell.2018.10.022.

Fundamental constraints in synchronous muscle limit superfast motor control in vertebrates.

Mead A, Osinalde N, Ortenblad N, Nielsen J, Brewer J, Vellema M Elife. 2017; 6.

PMID: 29165242 PMC: 5699865. DOI: 10.7554/eLife.29425.

References

Hein M, Hubner N, Poser I, Cox J, Nagaraj N, Toyoda Y . A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell. 2015; 163(3):712-23. DOI: 10.1016/j.cell.2015.09.053. View

Halbach S, Rigbolt K, Wohrle F, Diedrich B, Gretzmeier C, Brummer T . Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells. Cell Commun Signal. 2013; 11(1):30. PMC: 3640961. DOI: 10.1186/1478-811X-11-30. View

Zhou Y, Hanson E, Chen Y, Magnuson K, Chen M, Swann P . Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity. Proc Natl Acad Sci U S A. 1998; 94(25):13850-5. PMC: 28396. DOI: 10.1073/pnas.94.25.13850. View

Williams M, Tyznik A, Bevan M . Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature. 2006; 441(7095):890-3. PMC: 2776073. DOI: 10.1038/nature04790. View

Emlet D, Moscatello D, Godwin A, Wong A . A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature. 1996; 379(6565):560-4. DOI: 10.1038/379560a0. View

Hori T, Uchiyama T, Tsudo M, Umadome H, Ohno H, Fukuhara S . Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. Blood. 1987; 70(4):1069-72. View

Adams S, Aydin I, Celebi J . GAB2--a scaffolding protein in cancer. Mol Cancer Res. 2012; 10(10):1265-70. PMC: 3810274. DOI: 10.1158/1541-7786.MCR-12-0352. View

Olsen J, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P . Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006; 127(3):635-48. DOI: 10.1016/j.cell.2006.09.026. View

Gesbert F, Guenzi C, Bertoglio J . A new tyrosine-phosphorylated 97-kDa adaptor protein mediates interleukin-2-induced association of SHP-2 with p85-phosphatidylinositol 3-kinase in human T lymphocytes. J Biol Chem. 1998; 273(29):18273-81. DOI: 10.1074/jbc.273.29.18273. View

10.

Dengjel J, Kratchmarova I, Blagoev B . Receptor tyrosine kinase signaling: a view from quantitative proteomics. Mol Biosyst. 2009; 5(10):1112-21. DOI: 10.1039/b909534a. View

11.

Restifo N, Dudley M, Rosenberg S . Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol. 2012; 12(4):269-81. PMC: 6292222. DOI: 10.1038/nri3191. View

12.

Dengjel J, Kratchmarova I, Blagoev B . Mapping protein-protein interactions by quantitative proteomics. Methods Mol Biol. 2010; 658:267-78. DOI: 10.1007/978-1-60761-780-8_16. View

13.

Wada T, Nakashima T, Oliveira-dos-Santos A, Gasser J, Hara H, Schett G . The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis. Nat Med. 2005; 11(4):394-9. DOI: 10.1038/nm1203. View

14.

Lewitzky M, Kardinal C, Gehring N, Schmidt E, Konkol B, Eulitz M . The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif. Oncogene. 2001; 20(9):1052-62. DOI: 10.1038/sj.onc.1204202. View

15.

Zhang X, Lavoie G, Fort L, Huttlin E, Tcherkezian J, Galan J . Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility. Mol Cell Biol. 2013; 33(8):1657-70. PMC: 3624252. DOI: 10.1128/MCB.01353-12. View

16.

Friedmann M, Migone T, Russell S, Leonard W . Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc Natl Acad Sci U S A. 1996; 93(5):2077-82. PMC: 39912. DOI: 10.1073/pnas.93.5.2077. View

17.

Ortiz-Padilla C, Gallego-Ortega D, Browne B, Hochgrafe F, Caldon C, Lyons R . Functional characterization of cancer-associated Gab1 mutations. Oncogene. 2012; 32(21):2696-702. DOI: 10.1038/onc.2012.271. View

18.

Kamimura D, Bevan M . Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo. J Exp Med. 2007; 204(8):1803-12. PMC: 2118678. DOI: 10.1084/jem.20070543. View

19.

Seiffert M, Custodio J, Wolf I, Harkey M, Liu Y, Blattman J . Gab3-deficient mice exhibit normal development and hematopoiesis and are immunocompetent. Mol Cell Biol. 2003; 23(7):2415-24. PMC: 150735. DOI: 10.1128/MCB.23.7.2415-2424.2003. View

20.

Wohrle F, Daly R, Brummer T . Function, regulation and pathological roles of the Gab/DOS docking proteins. Cell Commun Signal. 2009; 7:22. PMC: 2747914. DOI: 10.1186/1478-811X-7-22. View